Accreditation, Credit, and Support
This educational activity is supported in part by independent grants from Gilead, ViiV, and Bavarian Nordic. See below for credits offered to SYNC participants for attending institutes, sessions, and plenaries — live or in-person — at SYNC 2026.
In support of improving patient care, HealthHIV is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity has been approved for AMA PRA Category 1 Credit™. Determination of exact number of credits is pending.
This activity is eligible for ANCC contact hours; the number of hours is pending.
This activity is eligible for ACPE credit; determination of available number of credits is pending review. See the final CPE activity announcement for specific details.
HealthHIV has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for AAPA Category 1 CME credits; the credit count is pending review of the agenda. PAs should only claim credit commensurate with the extent of their participation.
HealthHIV is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program.
Regulatory boards are the final authority on courses accepted for continuing education credit. The credit count is pending review of the agenda.
Target Audience
This activity is intended for physicians, physician assistants/physician associates, pharmacists, registered nurses, nurse practitioners, psychologists, social workers, dieticians, and other healthcare professionals who care for patients with HIV, STIs, viral hepatitis, COVID-19, MPXV, and substance use disorders.
Faculty and Disclosure of Conflicts of Interest
HealthHIV requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to HealthHIV policies.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.